Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis

Clinical trial NCT04133194 · UNKNOWN

Trial details

NCT number: NCT04133194
Sponsor: Flemming Bendtsen
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2019-11-28
Primary completion: 2024-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.